The Healthcare Industry Group Inc. announces the launch of their innovative Topigenix™ Wound Care Line

April 14, 2016   Naples, FL – April 14, 2016 – Topigenix™, a division of the Healthcare Industry Group, Inc. (HIG), announces the launch of a new wound care management method now available in the United States. The innovative wound care line includes three wound healing products: Topigenix Skin and Wound Cleanser, Topigenix Wound Gel and Topigenix Wound Cream. Topigenix products have been scientifically formulated to provide an optimum wound healing environment and are intended to work synergistically to improve patient outcomes, shorten healing time, and reduce the overall cost of patient wound care management. Topigenix Skin and Wound Cleanser cleans and decontaminates wounds, moistens and debrides, aids in reducing bleeding, decreasing swelling, preventing infection, and promoting healing. Topigenix Wound Gel is a hydrogel that absorbs exudate, moisturizes acute and chronic wounds and provides persistent decontamination of wounds. The hydrogel promotes optimal wound surface pH to support healing and is safe for both repeated and long-term use. Topigenix Wound Cream provides a moist wound healing environment while reducing swelling and minimizing discoloration associated with bruising. The cream prevents skin breakdown and when used in conjunction with the Topigenix Skin and Wound Cleanser and Wound Healing Gel, helps protect the surrounding wound area. All of the Topigenix Wound Care products are non-toxic, non-sensitizing and non-irritating to the skin. The products are now available and manufactured in the USA for Topigenix™. HIG offers pilot programs in LTC and Rehab facilities to determined best practice protocols and affirm product efficacy. Topigenix products are indicated for use with Stage I–IV diabetic and pressure ulcers, surgical incisions, first and second degree burns, cuts, abrasions,...